Fight Misinformation with These 11 Facts About ADHD
Unravel ADHD untruths and myths with these evidence-based facts.
Fight ADHD Lies with Science
Dispel untruths and myths about ADHD with these evidence-based facts, plus get more insights and strategies from ADDitude.
You may opt out at any time. Terms of Use and Privacy Policy .
Despite decades of evidence-backed research on ADHD and its treatments, misinformation and stigma are making a comeback.
ADHD is not a new or made-up condition. The hallmarks of ADHD — excessive hyperactivity, inattention, and impulsivity — have been described in medical literature since the 18th century. Before the term “ADHD” was coined, the condition was conceptualized through other descriptions, including “hyperkinetic disorder.”
As our understanding of ADHD has evolved, diagnostic rates have risen, reflecting increased awareness and a greater recognition of symptoms beyond hyperactivity in historically overlooked groups.
In this download, you will learn 11 irrefutable facts to challenge untruths and disinformation about ADHD. You can use the research findings to challenge untruths and disinformation about ADHD today.
For more essential facts about ADHD, see the World Federation of ADHD’s international consensus statement detailing more than 200 findings about the disorder.
View Article Sources
1Taylor E. (2011). Antecedents of ADHD: a historical account of diagnostic concepts. Attention Deficit and Hyperactivity Disorders, 3(2), 69–75. https://doi.org/10.1007/s12402-010-0051-x
2Faraone, S.V., & Larsson, H. (2019). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry,24(4), 562–575. https://doi.org/10.1038/s41380-018-0070-0
3Dey, M., Paz Castro, R., Haug, S., & Schaub, M. P. (2019). Quality of life of parents of mentally-ill children: a systematic review and meta-analysis. Epidemiology and Psychiatric Sciences, 28(5), 563–577. https://doi.org/10.1017/S2045796018000409
4Danielson, M.L., Claussen, A.H., Bitsko, R.H., Katz, S.M., Newsome, K., Blumberg, S.J., Kogan, M.D., & Ghandour, R. (2024). ADHD prevalence among U.S. children and adolescents in 2022: diagnosis, severity, co-occurring disorders, and treatment. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 53(3), 343–360. https://doi.org/10.1080/15374416.2024.2335625
5Ginsberg, Y., Quintero, J., Anand, E., Casillas, M., & Upadhyaya, H.P. (2014). Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. The primary care companion for CNS disorders, 16(3), PCC.13r01600. https://doi.org/10.4088/PCC.13r01600
6Harpin, V., Mazzone, L., Raynaud, J P., Kahle, J., & Hodgkins, P. (2016). Long-term outcomes of ADHD: a systematic review of self-esteem and social function. Journal of Attention Disorders, 20(4), 295–305. https://doi.org/10.1177/1087054713486516
7Li, L., Zhu, N., Zhang, L., Kuja-Halkola, R., D’Onofrio, B. M., Brikell, I., Lichtenstein, P., Cortese, S., Larsson, H., & Chang, Z. (2024). ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA, 331(10), 850–860. https://doi.org/10.1001/jama.2024.0851
8Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014). Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA psychiatry, 71(3), 319–325. https://doi.org/10.1001/jamapsychiatry.2013.4174
9Shaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A.G., & Arnold, L.E. (2012). A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Medicine, 10, 99. https://doi.org/10.1186/1741-7015-10-99
10Stein, M.A., Zulauf-McCurdy, C., & DelRosso, L.M. (2022). Attention deficit hyperactivity disorder medications and sleep. Child and Adolescent Psychiatric Clinics of North America, 31(3), 499–514. https://doi.org/10.1016/j.chc.2022.03.006
11 Faraone S.V. (2009). Using meta-analysis to compare the efficacy of medications for attention-deficit/hyperactivity disorder in youths. P&T: A Peer-Reviewed Journal for Formulary Management, 34(12), 678–694.
12Wolraich, M.L., Hagan, J.F., Jr, Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S.K., Froehlich, T., Frost, J., Holbrook, J.R., Lehmann, C. U., Lessin, H.R., Okechukwu, K., Pierce, K. L., Winner, J. D., Zurhellen, W., & SUBCOMMITTEE ON CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVE DISORDER (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 144(4), e20192528. https://doi.org/10.1542/peds.2019-2528
13Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 55(8), 878–885. https://doi.org/10.1111/jcpp.12164
14Levin, F.R., Mariani, J.J., Specker, S., Mooney, M., Mahony, A., Brooks, D.J., Babb, D., Bai, Y., Eberly, L.E., Nunes, E.V., & Grabowski, J. (2015). Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit/hyperactivity disorder and cocaine use disorder: a randomized clinical trial. JAMA Psychiatry, 72(6), 593–602. https://doi.org/10.1001/jamapsychiatry.2015.41
15Wilens, T E., Adler, L.A., Weiss, M.D., Michelson, D., Ramsey, J.L., Moore, R.J., Renard, D., Brady, K.T., Trzepacz, P.T., Schuh, L.M., Ahrbecker, L.M., Levine, L.R., & Atomoxetine ADHD/SUD Study Group (2008). Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug and Alcohol Dependence, 96(1-2), 145–154. https://doi.org/10.1016/j.drugalcdep.2008.02.009
16Kast, K.A., Rao, V., & Wilens, T.E. (2021). Pharmacotherapy for attention-deficit/hyperactivity disorder and retention in outpatient substance use disorder treatment: a retrospective cohort study. The Journal of Clinical Psychiatry, 82(2), 20m13598. https://doi.org/10.4088/JCP.20m13598
17Sibley, M.H., Arnold, L.E., Swanson, J.M., Hechtman, L.T., Kennedy, T.M., Owens, E., Molina, B.S.G., Jensen, P.S., Hinshaw, S.P., Roy, A., Chronis-Tuscano, A., Newcorn, J.H., Rohde, L.A., & MTA Cooperative Group (2022). Variable patterns of remission from ADHD in the multimodal treatment study of ADHD. The American Journal of Psychiatry, 179(2), 142–151. https://doi.org/10.1176/appi.ajp.2021.21010032
18Sibley, M.H., Kennedy, T.M., Swanson, J.M., Arnold, L.E., Jensen, P.S., Hechtman, L.T., Molina, B.S.G., Howard, A., Greenhill, L., Chronis-Tuscano, A., Mitchell, J.T., Newcorn, J.H., Rohde, L.A., & Hinshaw, S.P. (2024). Characteristics and predictors of fluctuating attention-deficit/hyperactivity disorder in the multimodal treatment of ADHD (MTA) study. The Journal of Clinical Psychiatry, 85(4), 24m15395. https://doi.org/10.4088/JCP.24m15395
Fight ADHD Lies with Science
Dispel untruths and myths about ADHD with these evidence-based facts, plus get more insights and strategies from ADDitude.
You may opt out at any time. Terms of Use and Privacy Policy .
